Daily non-political popular news in brief.

Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows

A once-a-day, short-term treatment with a drug compound substantially improved learning and memory in mice with Down syndrome symptoms, say researchers at the Stanford University School of Medicine and Lucile Packard Children’s Hospital.

Read more »

Keywords: drug, treatment, improves, learning, mice, down, syndrome, symptoms, stanford, packard, study, shows, improve, symptom, show

« Previous | Next »

Similar news on "Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows":

1. Pilot study shows withdrawal drug offers symptom relief to Crohn's sufferers
   02-02-2007 · EurekAlert!
   A Penn State College of Medicine pilot study suggests a low dose of naltrexone, a drug used to ease symptoms of alcohol and drug addiction, may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans. The study results were released online this week in an early edition of the American Journal of Gastroenterology.
   Similar news · Read more »
   
2. Drug blocks lethal motor-neuron disease in mice
   02-22-2007 · EurekAlert!
   Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
   Similar news · Read more »
   
3. Common preterm labor drug has more side effects than alternative
   06-29-2007 · EurekAlert!
   The drug most commonly used to arrest preterm labor, magnesium sulfate, is more likely than another common treatment to cause mild to serious side effects in pregnant women, according to a study from researchers at Lucile Packard Children's Hospital and Stanford University School of Medicine.
   Similar news · Read more »
   
4. New drug shows promise for treating epileptic seizures
   04-05-2007 · EurekAlert!
   A new study appearing in the latest issue of Epilepsia shows that a new drug called Eslicarbazepine (ESL) shows promise as a treatment for epilepsy patients whose symptoms remain uncontrolled with existing medications. A once-daily dose was shown to be most effective, offering patients added convenience as current treatments can involve several doses per day.
   Similar news · Read more »
   
5. New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis
   11-08-2007 · EurekAlert!
   The innovative new rheumatoid arthritis drug Actemra has been shown to significantly improve the signs and symptoms of rheumatoid arthritis in patients who failed to achieve an adequate response to traditional disease modifying agents. Exciting new data from the TOWARD1 study, being presented as a late breaker, at the American College of Rheumatology Annual Scientific Meeting in Boston, Nov. 6-11, reinforce the benefit of tackling RA through the inhibition of the IL-6 pathway.
   Similar news · Read more »
   
6. Mayo Clinic study indicates medication for ADHD may help student outcomes
   09-18-2007 · EurekAlert!
   In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.
   Similar news · Read more »
   
7. MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation
   06-25-2007 · EurekAlert!
   Researchers at the Picower Institute at MIT have, for the first time, reversed symptoms of mental retardation and autism in mice. The study may lead to new drug therapies for a leading inherited cause of mental retardation (Fragile X Syndrome) and some types of autism.
   Similar news · Read more »
   
8. Study shows that targeted antibiotics lead to prolonged improvement in IBS symptoms
   10-16-2006 · EurekAlert!
   Researchers at Cedars-Sinai Medical Center have found that a nonabsorbable antibiotic -- one that stays in the gut -- can be an effective long-term treatment for irritable bowel syndrome (IBS), a disease affecting more than 20 percent of Americans.
   Similar news · Read more »
   
9. Outwardly expressed anger affects some women's heart arteries, says a new women-only study
   01-12-2007 · EurekAlert!
   Researchers seeking to improve diagnostic and treatment tools for women with heart disease have found that the outward expression of anger and hostility is higher in certain women with suspected coronary artery disease. But anger and hostility also are associated with atypical cardiac symptoms in women who do not have angiographic evidence of heart disease. C. Noel Bairey Merz, principal investigator of the multicenter Women's Ischemia Syndrome Evaluation (WISE) Study, is available to discuss the research and its implications.
   Similar news · Read more »
   
10. Mold linked to asthma
    09-05-2007 · EurekAlert!
    A Cardiff University study has found that removing indoor mold improves the symptoms of people with asthma. Asthma UK figures show the prevalence of asthma in Wales is among the highest in the world, with 260,000 people receiving treatment for their asthma with the rate of hospital admissions for adults 12 percent more than anywhere else in the UK.
    Similar news · Read more »